AstraZeneca PLC officer Mani Sharma filed a Form 4 on November 10, 2026, disclosing the acquisition of one ordinary share on November 6, 2026, through the company's Share Incentive Plan.

Key Highlights

  • Reporting person: Mani Sharma, SVP, Group Controller and Head of Global Finance Services at AstraZeneca PLC (NASDAQ:AZN)
  • Transaction: Acquisition (Code A) of 1 ordinary share on November 6, 2026
  • Price paid: GBP 139.29 per share, converted to $186.24 at a rate of GBP 1.0000 to $1.3371 as published by the Board of Governors of the Federal Reserve System
  • Post-transaction ownership: 19,291.6989 ordinary shares held directly following the transaction
  • Plan basis: Shares acquired pursuant to the issuer's Share Incentive Plan

AstraZeneca Officer Sharma Reports Single Share Acquisition Under Share Incentive Plan

According to the Form 4 filed with the SEC on November 10, 2026, Mani Sharma, identified in the filing as SVP, Group Controller and Head of Global Finance Services of AstraZeneca PLC, reported the acquisition of 1 ordinary share on November 6, 2026. The filing indicates the transaction carried a price of GBP 139.29, which the filing states was "converted from British pounds sterling to United States dollars at a conversion rate of GBP1.0000 to $1.3371 on November 6, 2026 as published by the Board of Governors of the Federal Reserve System," yielding a U.S. dollar equivalent of $186.24.

The filing reports that the acquisition was made pursuant to the issuer's Share Incentive Plan. Following the reported transaction, Sharma's direct beneficial ownership of AstraZeneca ordinary shares stands at 19,291.6989 shares, as stated in Table I of the filing. No derivative securities transactions were reported in Table II.

The filing was signed by Mani Sharma and dated November 10, 2026. No amendment to a prior filing was indicated, and the form was filed by one reporting person. Sharma's address is listed as 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom.

What Was Disclosed

Mani Sharma, an officer of AstraZeneca PLC, disclosed the acquisition of 1 ordinary share on November 6, 2026, at GBP 139.29 (USD $186.24) under the company's Share Incentive Plan, bringing total direct beneficial ownership to 19,291.6989 shares.